Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 3
2007 1
2008 1
2011 1
2013 1
2017 1
2018 1
2019 1
2021 1
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Concepts in Oncolytic Adenovirus Therapy.
Mantwill K, Klein FG, Wang D, Hindupur SV, Ehrenfeld M, Holm PS, Nawroth R. Mantwill K, et al. Int J Mol Sci. 2021 Sep 29;22(19):10522. doi: 10.3390/ijms221910522. Int J Mol Sci. 2021. PMID: 34638863 Free PMC article. Review.
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Koch J, Schober SJ, Hindupur SV, Schöning C, Klein FG, Mantwill K, Ehrenfeld M, Schillinger U, Hohnecker T, Qi P, Steiger K, Aichler M, Gschwend JE, Nawroth R, Holm PS. Koch J, et al. Among authors: mantwill k. Nat Commun. 2022 Aug 10;13(1):4689. doi: 10.1038/s41467-022-32087-5. Nat Commun. 2022. PMID: 35948546 Free PMC article.
Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.
Ehrenfeld M, Segeth F, Mantwill K, Brockhaus C, Zhao Y, Ploner C, Kolk A, Gschwend JE, Nawroth R, Holm PS. Ehrenfeld M, et al. Among authors: mantwill k. J Virol. 2023 Jun 29;97(6):e0037023. doi: 10.1128/jvi.00370-23. Epub 2023 May 23. J Virol. 2023. PMID: 37219458 Free PMC article.
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Schober SJ, Schoening C, Eck J, Middendorf C, Lutsch J, Knoch P, von Ofen AJ, Gassmann H, Thiede M, Hauer J, Kolk A, Mantwill K, Gschwend JE, Burdach SEG, Nawroth R, Thiel U, Holm PS. Schober SJ, et al. Among authors: mantwill k. Clin Cancer Res. 2023 May 15;29(10):1996-2011. doi: 10.1158/1078-0432.CCR-22-1961. Clin Cancer Res. 2023. PMID: 36892582
Adenovirus Particle Quantification in Cell Lysates Using Light Scattering.
Hohl A, Ramms AS, Dohmen C, Mantwill K, Bielmeier A, Kolk A, Ruppert A, Nawroth R, Holm PS. Hohl A, et al. Among authors: mantwill k. Hum Gene Ther Methods. 2017 Oct;28(5):268-276. doi: 10.1089/hgtb.2017.052. Epub 2017 Aug 14. Hum Gene Ther Methods. 2017. PMID: 28806885
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.
Klawitter M, El-Ayoubi A, Buch J, Rüttinger J, Ehrenfeld M, Lichtenegger E, Krüger MA, Mantwill K, Koll FJ, Kowarik MC, Holm PS, Naumann U. Klawitter M, et al. Among authors: mantwill k. Int J Mol Sci. 2022 Sep 1;23(17):9965. doi: 10.3390/ijms23179965. Int J Mol Sci. 2022. PMID: 36077380 Free PMC article.
17 results